Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study

Michael Phillips, Kevin Gleeson, J Michael B Hughes, Joel Greenberg, Renee N Cataneo, Leigh Baker, W Patrick McVay
1999-06-05
Abstract:BackgroundMany volatile organic compounds (VOCs), principally alkanes and benzene derivatives, have been identified in breath from patients with lung cancer. We investigated whether a combination of VOCs could identify such patients.MethodsWe collected breath samples from 108 patients with an abnormal chest radiograph who were scheduled for bronchoscopy. The samples were collected with a portable apparatus, then assayed by gas chromatography and mass spectroscopy. The alveolar gradient of each breath VOC, the difference between the amount in breath and in air, was calculated. Forward stepwise discriminant analysis was used to identify VOCs that discriminated between patients with and without lung cancer.FindingsLung cancer was confirmed histologically in 60 patients. A combination of 22 breath VOCs, predominantly alkanes, alkane derivatives, and benzene derivatives, discriminated …
What problem does this paper attempt to address?